CN110558379A - hypoallergenic infant formula dairy product and preparation method thereof - Google Patents
hypoallergenic infant formula dairy product and preparation method thereof Download PDFInfo
- Publication number
- CN110558379A CN110558379A CN201910901639.XA CN201910901639A CN110558379A CN 110558379 A CN110558379 A CN 110558379A CN 201910901639 A CN201910901639 A CN 201910901639A CN 110558379 A CN110558379 A CN 110558379A
- Authority
- CN
- China
- Prior art keywords
- powder
- product
- parts
- milk
- infant formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 28
- 230000000774 hypoallergenic effect Effects 0.000 title claims abstract description 24
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 102
- 235000013336 milk Nutrition 0.000 claims abstract description 22
- 239000008267 milk Substances 0.000 claims abstract description 22
- 210000004080 milk Anatomy 0.000 claims abstract description 22
- 241000186315 Lactobacillus paracasei N1115 Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 15
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 14
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 14
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 14
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 14
- 244000000626 Daucus carota Species 0.000 claims abstract description 13
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 13
- 238000001816 cooling Methods 0.000 claims abstract description 13
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 11
- 235000020185 raw untreated milk Nutrition 0.000 claims abstract description 11
- 238000001694 spray drying Methods 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 8
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 7
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 7
- 239000005862 Whey Substances 0.000 claims abstract description 7
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 7
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 7
- 229960003178 choline chloride Drugs 0.000 claims abstract description 7
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000021323 fish oil Nutrition 0.000 claims abstract description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 7
- 239000008101 lactose Substances 0.000 claims abstract description 7
- 239000011707 mineral Substances 0.000 claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 7
- 235000021119 whey protein Nutrition 0.000 claims abstract description 7
- 244000068988 Glycine max Species 0.000 claims abstract description 5
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 5
- 238000004806 packaging method and process Methods 0.000 claims abstract description 4
- 229940067631 phospholipid Drugs 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims description 8
- 240000006499 Flammulina velutipes Species 0.000 claims description 7
- 235000016640 Flammulina velutipes Nutrition 0.000 claims description 7
- 238000007580 dry-mixing Methods 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- -1 compound vitamin Chemical class 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 235000020183 skimmed milk Nutrition 0.000 claims description 4
- 229940073490 sodium glutamate Drugs 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 235000019764 Soybean Meal Nutrition 0.000 claims description 2
- 239000004455 soybean meal Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 abstract description 13
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 9
- 208000026935 allergic disease Diseases 0.000 abstract description 8
- 230000000172 allergic effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000007815 allergy Effects 0.000 abstract description 6
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 238000004140 cleaning Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 36
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 239000013566 allergen Substances 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 235000020215 hypoallergenic milk formula Nutrition 0.000 description 2
- 230000006058 immune tolerance Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 240000007440 Agaricus campestris Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010014198 Eczema infantile Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Dairy Products (AREA)
Abstract
The invention provides a hypoallergenic infant formula dairy product, which is prepared from the following raw materials: raw milk, desalted whey powder, lactose, 1, 3-dioleate-2-palmitic acid triglyceride powder, soybean powder, galacto-oligosaccharide, concentrated whey protein powder, fructo-oligosaccharide, phospholipid, arachidonic acid powder, calcium carbonate, fish oil powder, compound vitamins, compound minerals, choline chloride, nucleotide, chickpea powder, needle mushroom powder, carrot powder and lactobacillus paracasei N1115 powder. The invention also provides a preparation method of the hypoallergenic infant formula dairy product, which comprises the following steps in sequence: (1) checking and accepting raw milk; (2) cleaning milk; (3) pre-pasteurizing; (4) homogenizing and sterilizing; (5) fermenting; (6) spray drying; (7) cooling; (8) mixing in a dry method; (9) and packaging to obtain the product. The dairy product is suitable for allergic infants, and has the effects of reducing the allergy risk and even generating anti-allergy effect.
Description
Technical Field
The invention relates to the technical field of dairy products, in particular to a hypoallergenic infant formula dairy product and a preparation method thereof.
Background
Cow milk protein allergy is most prevalent in infant food allergy. About 0.3-7.5% of infants in the world suffer from cow milk protein allergy, wherein about 1.5-7.5% of infants in developed countries in Europe and America suffer from the cow milk protein allergy, and about 8% of infants in China suffer from the cow milk protein allergy. Casein, beta-lactoglobulin and alpha-lactalbumin existing in cow milk are main allergen, and can cause infantile eczema, gastrointestinal reaction and the like, and even influence the growth and development of infants.
at present, the number of allergic people of infants in China is rapidly increased, and because the common infant formula powder contains protein allergens in cow milk, the infant allergic reaction can be caused, more and more consumers can select hypoallergenic infant formula milk powder as a method for preventing allergy. The hypoallergenic formula milk powder on the market at present is still in the blank field, but the hypoallergenic formula milk powder in China has a very wide market, and the market capacity of the hypoallergenic infant formula milk powder in China to 2020 is at least 85 hundred million yuan (million yuan) calculated by 8 percent. Therefore, the problem to be solved by the current consumer market is to prepare the formulated milk powder with low sensitization.
Disclosure of Invention
The invention aims to solve the technical problem of providing a hypoallergenic infant formula dairy product and a preparation method thereof. The dairy product is suitable for allergic infants, and has the effects of reducing the allergy risk and even generating anti-allergy effect.
the lactobacillus paracasei N1115 is separated and screened from traditional fermented milk products in inner Mongolia of China, is disclosed in patent CN201110357058.8, has been preserved in the strain collection center of the institute of microbiology of Chinese academy of sciences in 2011 for 3 months, and has the preservation number of CGMCC 4691.
in order to solve the technical problems, the technical scheme adopted by the invention is as follows:
a hypoallergenic infant formula dairy product comprises the following raw materials in parts by weight: 80-90 parts of raw milk, 5-15 parts of desalted whey powder, 4-6 parts of lactose, 3-5 parts of 1, 3-dioleate-2-palmitic acid triglyceride powder, 2-3 parts of soybean meal, 0.5-1.5 parts of galacto-oligosaccharide, 0.5-1 part of concentrated whey protein powder, 0.3-0.5 part of fructo-oligosaccharide, 0.1-0.5 part of phospholipid, 0.1-0.3 part of arachidonic acid powder, 0.1-0.5 part of calcium carbonate, 0.1-0.3 part of fish oil powder, 0.06-0.16 part of compound vitamin, 0.05-0.15 part of compound mineral substance, 0.05-0.15 part of choline chloride, 0.01-0.05 part of nucleotide, 0.5-1 part of eagle pea powder, 0.3-0.7 part of flammulina velutipes powder, 0.4-0.8 part of carrot powder and 1-2 parts of lactobacillus paracasei N bacteria powder.
Preferably, the hypoallergenic infant formula dairy product comprises the following raw materials in parts by weight: 8-10 parts of skim milk, 5-7 parts of maltodextrin, 5-7 parts of trehalose, 1-2 parts of L-sodium glutamate and 0.5-1 part of sorbitol;
The Lactobacillus paracasei N1115 powder also contains Lactobacillus paracasei N11150.8 × 1012 -1.2×1012CFU/kg。
the invention also provides a preparation method of the hypoallergenic infant formula dairy product, which comprises the following steps in sequence:
(1) Checking and accepting raw milk, and standardizing the raw milk to obtain a product A;
(2) purifying milk, namely performing impurity separation on the product A by a milk purifier to obtain a product B;
(3) pre-pasteurizing, namely pasteurizing the product B at 52-58 ℃, and cooling to obtain a product C;
(4) Homogenizing, heating the product C to 65-70 deg.C, homogenizing, sterilizing, and cooling to obtain product D;
(5) fermenting, namely adding lactobacillus paracasei N1115 bacteria powder, chickpea powder, needle mushroom powder and carrot powder into the product D, stirring until the bacteria powder, the chickpea powder, the needle mushroom powder and the carrot powder are dissolved, fermenting until the acidity reaches 75 DEG T, stirring, and demulsifying to obtain a product E;
(6) spray drying, namely spray drying the product E to obtain a product F;
(7) cooling, cooling the product F;
(8) Dry mixing, namely dry mixing the cooled product F with desalted whey powder, lactose, 1, 3-dioleate-2-palmitic acid triglyceride powder, soybean powder, galacto-oligosaccharide, concentrated whey protein powder, fructo-oligosaccharide, phospholipid, arachidonic acid powder, calcium carbonate, fish oil powder, compound vitamin, compound mineral substance, choline chloride, nucleotide and lactobacillus paracasei N1115 powder for more than 30 min;
(9) and packaging to obtain the product.
The lactobacillus paracasei N1115 powder is added again in the step (8) of the method of the invention because the lactobacillus paracasei N1115 is lost in the spray drying in the step (6), and the dry mixing method adds the lactobacillus paracasei N1115 powder to supplement the loss amount.
In the preparation method, preferably, in the spray drying in the step (6), the spray pressure is 190-240bar, the air inlet temperature is 150-170 ℃, the air exhaust temperature is 85-90 ℃, and the pressure in the drying chamber is-110 to-90 Pa.
In the formula of the invention, chickpeas, flammulina velutipes and carrots are added. The chickpea is rich in protein, various amino acids, edible fiber, trace elements and vitamins, and the protein has higher efficacy ratio, biological utilization value and digestibility, can provide more nutrition for infants, and does not increase the digestion burden. The chickpea sugar alcohol contained in the milk powder is functional galactooligosaccharide, has the effects of improving the intestinal micro-ecological environment, promoting the generation and absorption of nutrient substances in the intestinal tract, improving the immunity of the organism and the like, and can relieve the allergic symptoms of infants. The chickpea sugar alcohol can generate butyric acid through fermentation, and the butyric acid can promote immune tolerance so as to prevent the infant from generating allergy.
Golden mushroom: the needle mushroom has high amino acid content higher than that of common mushrooms, especially high lysine content, can promote intelligence development and growth of children, has multiple functional proteins and polysaccharides, can promote immunity enhancement of human bodies, resist tumors, and also has the effect of inhibiting allergic diseases such as asthma, rhinitis and eczema.
Carrot: beta-carotene contained in carrot can effectively prevent anaphylaxis and has inhibitory effect on I type anaphylactic reaction diseases such as pollinosis and atropine dermatitis.
According to the invention, butyric acid generated by fermentation of chickpeas promotes immune tolerance in intestinal tracts, thereby preventing allergy; the immune regulatory protein of the flammulina velutipes has the effects of preventing, controlling and treating various immune reactions and allergic diseases, and meanwhile, polysaccharides, phenols and ketones contained in the flammulina velutipes have the function of resisting oxidation and can remove harmful oxidation substances generated by the allergic reactions; beta-carotene has the effect of regulating the histamine balance in blood, thereby inhibiting allergic reactions. The components of the dairy product are matched with each other, particularly three components of chickpea, flammulina velutipes and beta-carotene are matched with each other in a synergistic way in the aspects of prevention, symptoms, allergic processes and the like, so that the antiallergic effect is enhanced, and meanwhile, polysaccharide and protein contained in the chickpea and the flammulina velutipes have the functions of promoting fermentation and protecting the N1115 strain.
compared with the prior art, the invention has the following advantages:
(1) according to the invention, the lactobacillus paracasei N1115 is used for fermenting the milk, so that protein allergens in the milk are destroyed, and the allergenicity of the product is reduced.
(2) The invention improves the anti-allergic effect of the product by the compatibility of the raw materials and the fermentation of the raw materials and the N1115 strain.
(3) The hypoallergenic infant milk product prepared by the invention is suitable for allergic infants, and can reduce or improve infant allergic symptoms such as eczema, gastrointestinal symptoms and the like while ensuring nutrition required by infant growth and development, and promote healthy development of allergic infants.
(4) The desensitizing process is simple, deep processing of the raw materials is not required, and the nutrition of the raw materials is effectively maintained.
Detailed Description
the present invention is described in further detail below with reference to specific examples, which are intended to be illustrative only and not limiting.
Example 1:
a hypoallergenic infant formula dairy product comprises the following raw materials in parts by weight: 87kg of raw milk, 5kg of desalted whey powder, 6kg of lactose, 4.5kg of 1, 3-dioleate-2-palmitic acid triglyceride powder, 2.5kg of soybean powder, 0.8kg of galacto-oligosaccharide, 0.8kg of concentrated whey protein powder, 0.4kg of fructo-oligosaccharide, 0.3kg of phospholipid, 0.2kg of arachidonic acid powder, 0.5kg of calcium carbonate, 0.3kg of fish oil powder, 0.08kg of compound vitamin, 0.15kg of compound mineral substance, 0.1kg of choline chloride, 0.01kg of nucleotide, 1kg of chickpea powder, 0.3kg of needle mushroom powder, 0.6kg of carrot powder and 1kg of 1115 lactobacillus paracasei N bacteria powder.
the lactobacillus paracasei N1115 powder comprises the following raw materials in parts by weight: 9kg of skim milk, 6kg of maltodextrin, 6kg of trehalose, 1kg of L-sodium glutamate and 0.6kg of sorbitol.
the lactobacillus paracasei N1115 powder comprises the following raw materials in parts by weight: 9kg of skim milk, 6kg of maltodextrin, 6kg of trehalose, 1kg of L-sodium glutamate and 0.6kg of sorbitol.
The content of lactobacillus paracasei N1115 in the lactobacillus paracasei N1115 powder is 1 multiplied by 1012 CFU/kg。
examples 2 to 5:
Examples 2-5 are individually hypoallergenic infant formula dairy products. The raw material composition of the dairy product is the same as that of the example 1, except that the dosage of each raw material is different, and the specific mixture ratio of the raw materials is shown in the following table 1:
TABLE 1 raw material ratios of Dairy products in examples 2-5
the raw material composition of the lactobacillus paracasei N1115 powder is the same as that of the powder in the example 1, except that the dosage of each raw material is different, and the specific ratio of the raw materials is as shown in the following table 2:
TABLE 2 raw material ratio of Lactobacillus paracasei N1115 powder in examples 2-5
Example 6 preparation method of hypoallergenic infant formula milk product
This example provides a method of preparing a hypoallergenic infant formula milk product of any one of examples 1 to 5, comprising the following steps performed in order:
(1) Checking and accepting raw milk, and standardizing the raw milk to obtain a product A;
(2) Purifying milk, namely performing impurity separation on the product A by a milk purifier to obtain a product B;
(3) pre-pasteurizing, namely pasteurizing the product B at 55 ℃, and cooling to obtain a product C;
(4) Homogenizing, heating the product C to 68 ℃, homogenizing, sterilizing and cooling to obtain a product D;
(5) Fermenting, namely adding lactobacillus paracasei N1115 bacteria powder, chickpea powder, needle mushroom powder and carrot powder into the product D, stirring until the bacteria powder, the chickpea powder, the needle mushroom powder and the carrot powder are dissolved, fermenting until the acidity reaches 75 DEG T, stirring, and demulsifying to obtain a product E;
(6) Spray drying, namely spray drying the product E to obtain a product F; the spraying pressure is 230bar, the air inlet temperature is 165 ℃, the air outlet temperature is 88 ℃ and the pressure in the drying chamber is-105 Pa.
(7) Cooling, cooling the product F;
(8) dry mixing, namely dry mixing the cooled product F with desalted whey powder, lactose, 1, 3-dioleate-2-palmitic acid triglyceride powder, soybean powder, galacto-oligosaccharide, concentrated whey protein powder, fructo-oligosaccharide, phospholipid, arachidonic acid powder, calcium carbonate, fish oil powder, compound vitamin, compound mineral substance, choline chloride, nucleotide and lactobacillus paracasei N1115 powder for 40 min;
(9) and packaging to obtain the product.
Example 7-10A method for preparing a hypoallergenic infant formula milk product
examples 7 to 10 are methods of preparing hypoallergenic infant formula milk products, respectively, the preparation steps of which are the same as those of example 6, except that the parameters of the steps are different, and the differences are as follows in table 3:
TABLE 3 different parameters of examples 7-10
Example 11:
Performance testing of hypoallergenic infant formula dairy products provided in examples 1-5.
10 children with allergic eczema were selected and divided into a test group and a control group. Performing basic treatment on a control group, and feeding with common formula milk powder; the test group is fed with hypoallergenic infant formula milk products while undergoing basal therapy. Clinical indications and scores were recorded and evaluated for efficacy before, on day 7, day 14 and day 28 of the study. And evaluating the severity of eczema by using integral, and mainly selecting two indexes of skin eczema range and skin damage severity. The scale of scoring for both indices: 0-3 min. 0= none, 1= mild, 2= moderate, 3= severe. The overall score is the sum of the two indices. The results are shown in table 4 below:
TABLE 4 evaluation of the efficacy of the test group and the control group
The results show that the scoring difference of the tested two groups of children patients is small before the experiment; on the 14 th day and the 28 th day of the experiment, the eczema scores of the infants in the test group are respectively (1.6 +/-0.48) and (0.6 +/-0.48), which are obviously lower than those of the infants in the control group (3.4 +/-0.48) and (2 +/-0.32). The low-sensitization infant formula dairy product provided by the invention is proved to effectively reduce the symptoms of allergy infants.
Claims (4)
1. A hypoallergenic infant formula dairy product is characterized in that the dairy product is prepared from the following raw materials in parts by weight: 80-90 parts of raw milk, 5-15 parts of desalted whey powder, 4-6 parts of lactose, 3-5 parts of 1, 3-dioleate-2-palmitic acid triglyceride powder, 2-3 parts of soybean meal, 0.5-1.5 parts of galacto-oligosaccharide, 0.5-1 part of concentrated whey protein powder, 0.3-0.5 part of fructo-oligosaccharide, 0.1-0.5 part of phospholipid, 0.1-0.3 part of arachidonic acid powder, 0.1-0.5 part of calcium carbonate, 0.1-0.3 part of fish oil powder, 0.06-0.16 part of compound vitamin, 0.05-0.15 part of compound mineral substance, 0.05-0.15 part of choline chloride, 0.01-0.05 part of nucleotide, 0.5-1 part of eagle pea powder, 0.3-0.7 part of flammulina velutipes powder, 0.4-0.8 part of carrot powder and 1-2 parts of lactobacillus paracasei N bacteria powder.
2. the hypoallergenic infant formula dairy product according to claim 1, characterized in that the raw materials from which the lactobacillus paracasei N1115 powder is made comprise, in parts by weight: 8-10 parts of skim milk, 5-7 parts of maltodextrin, 5-7 parts of trehalose, 1-2 parts of L-sodium glutamate and 0.5-1 part of sorbitol;
The Lactobacillus paracasei N1115 powder also contains Lactobacillus paracasei N11150.8 × 1012 -1.2×1012CFU/kg。
3. the method for preparing a hypoallergenic infant formula milk product according to claim 1 or 2, characterized in that it comprises the following steps carried out in sequence:
(1) Checking and accepting raw milk, and standardizing the raw milk to obtain a product A;
(2) Purifying milk, namely performing impurity separation on the product A by a milk purifier to obtain a product B;
(3) pre-pasteurizing, namely pasteurizing the product B at 52-58 ℃, and cooling to obtain a product C;
(4) Homogenizing, heating the product C to 65-70 deg.C, homogenizing, sterilizing, and cooling to obtain product D;
(5) Fermenting, namely adding lactobacillus paracasei N1115 bacteria powder, chickpea powder, needle mushroom powder and carrot powder into the product D, stirring until the bacteria powder, the chickpea powder, the needle mushroom powder and the carrot powder are dissolved, fermenting until the acidity reaches 75 DEG T, stirring, and demulsifying to obtain a product E;
(6) Spray drying, namely spray drying the product E to obtain a product F;
(7) cooling, cooling the product F;
(8) Dry mixing, namely dry mixing the cooled product F with desalted whey powder, lactose, 1, 3-dioleate-2-palmitic acid triglyceride powder, soybean powder, galacto-oligosaccharide, concentrated whey protein powder, fructo-oligosaccharide, phospholipid, arachidonic acid powder, calcium carbonate, fish oil powder, compound vitamin, compound mineral substance, choline chloride, nucleotide and lactobacillus paracasei N1115 powder for more than 30 min;
(9) and packaging to obtain the product.
4. the method for preparing the hypoallergenic infant formula milk product according to claim 3, wherein in the spray drying in the step (6), the spray pressure is 190-240bar, the air inlet temperature is 150-170 ℃, the air outlet temperature is 85-90 ℃, and the pressure in the drying chamber is-110 Pa to-90 Pa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910901639.XA CN110558379A (en) | 2019-09-23 | 2019-09-23 | hypoallergenic infant formula dairy product and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910901639.XA CN110558379A (en) | 2019-09-23 | 2019-09-23 | hypoallergenic infant formula dairy product and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110558379A true CN110558379A (en) | 2019-12-13 |
Family
ID=68781825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910901639.XA Withdrawn CN110558379A (en) | 2019-09-23 | 2019-09-23 | hypoallergenic infant formula dairy product and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110558379A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110999984A (en) * | 2019-12-24 | 2020-04-14 | 石家庄君乐宝乳业有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
-
2019
- 2019-09-23 CN CN201910901639.XA patent/CN110558379A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110999984A (en) * | 2019-12-24 | 2020-04-14 | 石家庄君乐宝乳业有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111990462A (en) | Infant formula containing protein composition and preparation method thereof | |
CN105360319A (en) | Child development formula milk powder and preparation method thereof | |
CN107668211B (en) | Infant formula goat milk powder for enhancing immune function and preparation method thereof | |
CN103271274B (en) | Nutrient health-care porridge | |
CN107712874A (en) | Depth hydrolysis' protein prescription powder and technique manufacturing method | |
CN103168839A (en) | Preparation process of infant formula milk powder | |
CN112167360A (en) | Low-sensitization infant formula goat milk powder | |
CN108669563A (en) | A kind of composition, its application and strengthen immunity, the product for improving allergy | |
CN110558379A (en) | hypoallergenic infant formula dairy product and preparation method thereof | |
CN102008050B (en) | Eight-cereal mixed rice capable of being cooked quickly and synchronously and processing method thereof | |
CN110999984A (en) | Hypoallergenic infant formula milk powder and preparation method thereof | |
CN110604297A (en) | Special medical food for old people and preparation method thereof | |
CN106417596A (en) | Zinc-rich yogurt and preparation method thereof | |
Kant et al. | The benefits of consuming soya milk-A review | |
RU2458538C1 (en) | Dietary, prophylactic and functional food product with probiotic b for sport alimentation | |
CN107712521A (en) | A kind of Rosa roxburghii fermented beverage and preparation method thereof | |
CN112753921A (en) | Cereal beverage with intestinal flora regulating function and preparation method thereof | |
Kusuma et al. | Naturally acquired lactic acid bacteria from fermented cassava improves nutrient and anti-dysbiosis activity of soy tempeh | |
CN110338265A (en) | A kind of additive for feed for piglets and preparation method thereof | |
CN110623077A (en) | Method for preparing plant milk powder by using cell agricultural technology | |
CN109090242A (en) | A kind of royal jelly Yoghourt and preparation method thereof | |
Barugahara et al. | Performance of nutritionally optimized millet porridges as complementary food for children from low socio-economic status households in Bujenje county, western Uganda | |
RU2677219C1 (en) | Composition for obtaining fermented milk product | |
CN104996947B (en) | A kind of preparation method of original sugarcane vinegar pickled products | |
Lu | Chemical properties and probiotics survivability of symbiotic coconut yogurt using polymerized whey protein as a gelation agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20191213 |